BMO Capital Markets Issues Positive Forecast for DuPont de Nemours (NYSE:DD) Stock Price

DuPont de Nemours (NYSE:DDFree Report) had its price objective raised by BMO Capital Markets from $50.00 to $60.00 in a research note published on Thursday,Benzinga reports. BMO Capital Markets currently has an outperform rating on the basic materials company’s stock.

DD has been the topic of a number of other research reports. Jefferies Financial Group increased their price objective on DuPont de Nemours from $51.00 to $59.00 and gave the company a “buy” rating in a report on Wednesday. Mizuho increased their price target on DuPont de Nemours from $46.00 to $52.00 and gave the company an “outperform” rating in a report on Tuesday. KeyCorp lifted their price target on shares of DuPont de Nemours from $51.00 to $57.00 and gave the company an “overweight” rating in a research report on Wednesday. JPMorgan Chase & Co. upped their price objective on shares of DuPont de Nemours from $48.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday, January 16th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of DuPont de Nemours in a research note on Monday, December 22nd. Twelve analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $50.46.

Read Our Latest Report on DD

DuPont de Nemours Stock Performance

Shares of DD stock opened at $49.34 on Thursday. The firm has a market cap of $20.67 billion, a P/E ratio of -26.53, a PEG ratio of 3.66 and a beta of 1.10. The stock’s 50-day moving average is $43.10 and its two-hundred day moving average is $37.07. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.42 and a quick ratio of 1.63. DuPont de Nemours has a fifty-two week low of $22.50 and a fifty-two week high of $52.66.

DuPont de Nemours (NYSE:DDGet Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The basic materials company reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.03. The firm had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.69 billion. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. DuPont de Nemours’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the prior year, the company posted $1.13 earnings per share. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. Analysts predict that DuPont de Nemours will post 4.38 earnings per share for the current fiscal year.

DuPont de Nemours declared that its Board of Directors has approved a share repurchase plan on Thursday, November 6th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the basic materials company to purchase up to 12.2% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s management believes its stock is undervalued.

Insiders Place Their Bets

In other news, SVP Erik T. Hoover sold 6,005 shares of the firm’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $39.79, for a total transaction of $238,938.95. Following the completion of the transaction, the senior vice president directly owned 112,101 shares of the company’s stock, valued at approximately $4,460,498.79. This trade represents a 5.08% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Lori Koch sold 9,011 shares of DuPont de Nemours stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $39.46, for a total transaction of $355,574.06. Following the sale, the chief executive officer owned 288,326 shares in the company, valued at approximately $11,377,343.96. This trade represents a 3.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.61% of the stock is owned by insiders.

Institutional Investors Weigh In On DuPont de Nemours

Institutional investors and hedge funds have recently made changes to their positions in the company. Advisors Asset Management Inc. boosted its position in DuPont de Nemours by 588.2% in the fourth quarter. Advisors Asset Management Inc. now owns 2,918 shares of the basic materials company’s stock valued at $117,000 after buying an additional 2,494 shares in the last quarter. FineMark National Bank & Trust grew its holdings in DuPont de Nemours by 21.3% during the 4th quarter. FineMark National Bank & Trust now owns 13,894 shares of the basic materials company’s stock worth $559,000 after acquiring an additional 2,438 shares during the last quarter. Advocate Investing Services LLC bought a new stake in DuPont de Nemours during the 4th quarter worth about $68,000. Federation des caisses Desjardins du Quebec increased its holdings in shares of DuPont de Nemours by 36.0% in the fourth quarter. Federation des caisses Desjardins du Quebec now owns 71,105 shares of the basic materials company’s stock valued at $2,858,000 after purchasing an additional 18,831 shares in the last quarter. Finally, HRT Financial LP bought a new stake in shares of DuPont de Nemours during the fourth quarter worth $8,669,000. Institutional investors and hedge funds own 73.96% of the company’s stock.

Key DuPont de Nemours News

Here are the key news stories impacting DuPont de Nemours this week:

  • Positive Sentiment: Multiple major brokers raised price targets and kept buy/overweight calls (Citigroup, Jefferies, UBS, Wells Fargo, KeyCorp, BMO, Wolfe), boosting upside thesis and supporting the stock’s recent rally. Wolfe Research Raises PT
  • Positive Sentiment: DuPont reported better‑than‑expected Q4 results and provided FY guidance, which pushed the shares to a one‑year high and underpins the upgrades. Q4 Results & Guidance
  • Positive Sentiment: Product recognition: DuPont’s FilmTec™ Fortilife™ XC160UHP reverse‑osmosis element was named an Edison Awards finalist — a modest positive for long‑term growth in water/wastewater markets. Edison Awards Finalist
  • Neutral Sentiment: Morgan Stanley remains on a hold rating for DD, which tempers the otherwise bullish analyst momentum and gives some investors pause. Morgan Stanley Hold
  • Neutral Sentiment: Several retail/investor pieces question whether the recent run makes DD less attractive near‑term (“Is it too late…”), highlighting valuation concerns that can limit further immediate buying. Valuation Commentary
  • Negative Sentiment: Net effect today: profit‑taking and selling into strength after the multi‑broker upgrade wave and the one‑year high—mixed analyst signals (some holds/valuation cautions) left the stock vulnerable to a pullback on higher volume.

DuPont de Nemours Company Profile

(Get Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

Featured Articles

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.